Emergency authorization for COVID-19 vaccine asked by Johnson & Johnson

US health regulators have been asked by Johnson & Johnson to authorize its single-dose COVID-19 vaccine for emergency use. The vaccine has had a rate of 66 percent of preventing infections in its large global trials. The supply of COVID-19 vaccines in the United States could be boosted with the single dose vaccine and could help increase the rate of the vaccination process.